Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

New York, January 13, 2026, 11:31 EST — Regular session Moderna shares were up $3.97, or 11.7%, at $37.81 by late morning in New York, lifting the vaccine maker to one of the stronger movers in biotech trading. The bounce comes as investors try to pin down what “post-pandemic Moderna” looks like — smaller, more volatile, and still dependent on seasonal vaccine demand that can shift fast. The company’s early look at 2025 is being read as a test of whether the slide has finally slowed. Moderna said it expects about $1.9 billion in 2025 sales, near the top end
13 January 2026
····
TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

New York, Jan 13, 2026, 11:23 EST — Regular session underway TTM Technologies shares surged roughly 19% Tuesday, hitting $92.84 late morning. The circuit-board manufacturer pushed higher on strong volume, continuing its recent rally. Investors zeroed in on TTM’s upcoming slot at the Needham Growth Conference in New York. CEO Edwin Roks and CFO Dan Boehle were set to speak early Tuesday. (TTM Technologies, Inc.) This year’s Needham event spans several days, combining virtual and in-person sessions and attracting hundreds of companies. This format tends to funnel quick capital into high-momentum stocks. (Needham & Company) TTM is often described as
13 January 2026
·····
UiPath stock slides after CEO Daniel Dines sells shares — what PATH investors watch next

UiPath stock slides after CEO Daniel Dines sells shares — what PATH investors watch next

New York, Jan 13, 2026, 11:14 EST — Regular session Shares of UiPath Inc dropped roughly 7.7% to $15.92 on Tuesday following a regulatory filing that revealed new insider selling at the automation software company. The stock had climbed to $17.63 earlier in the day. This shift is crucial as UiPath returns to the spotlight while investors assess enterprise spending on automation and AI. With the fiscal quarter closing, traders latch onto any sign of subscription growth—or its absence. Insider sales happen regularly, but they tend to draw notice when a stock is volatile and lacks an earnings report to
13 January 2026
·····
Intel stock pops after KeyBanc upgrade, $60 target as AI server demand tightens

Intel stock pops after KeyBanc upgrade, $60 target as AI server demand tightens

NEW YORK, January 13, 2026, 11:14 EST Intel (INTC.O) shares surged roughly 6% Tuesday following KeyBanc Capital Markets’ upgrade to “overweight,” signaling expectations for the stock to outperform. The firm also raised its price target to $60. Intel’s stock climbed 6.4% to $46.88 in late morning deals. (Barron’s) The call comes as Intel is already on a hot streak, soaring 27% this year after an 84% jump in 2025, with investors hunting for the next AI-driven winners. KeyBanc’s John Vinh described Intel’s AI efforts as still “nascent,” but noted the company is gaining traction thanks to growing data-center investments. (MarketWatch)
13 January 2026
·····
SMCI stock slides after Goldman starts Super Micro at Sell and flags margin downside

SMCI stock slides after Goldman starts Super Micro at Sell and flags margin downside

New York, January 13, 2026, 11:07 EST Shares of Super Micro Computer (SMCI) fell on Tuesday after Goldman Sachs assumed coverage of the AI-server maker with a Sell rating, warning profit margins could weaken further even as demand for artificial intelligence (AI) hardware stays strong. The stock was down about 6.0% at $28.31 as of 10:51 a.m. EST. (Investing.com) The call lands at a touchy moment for Super Micro, which sits in the middle of the AI buildout but is being judged less on how fast it ships boxes and more on what it keeps after costs. For a stock
13 January 2026
·····
Intel stock jumps near 6% on KeyBanc upgrade — and a filing shows a big holder cut back

Intel stock jumps near 6% on KeyBanc upgrade — and a filing shows a big holder cut back

NEW YORK, Jan 13, 2026, 11:07 EST Intel shares climbed 5.9% to $46.64 by 11:07 a.m. EST Tuesday, on roughly 69 million shares traded. Advanced Micro Devices also jumped, up 5.0% in early trading. Intel’s surge is significant because its strong start to the year has morphed into a showdown between optimism over “AI spillover” and lingering doubts about its execution. Server demand linked to AI investments has emerged as a key measure, with traders scrutinizing each data point as a verdict on the company’s prospects. KeyBanc’s John Vinh raised Intel to “Overweight” from “Sector Weight,” upping his price target
13 January 2026
······
Joby Aviation stock slides in New York trade — what’s moving JOBY after CPI

Joby Aviation stock slides in New York trade — what’s moving JOBY after CPI

New York, Jan 13, 2026, 10:49 EST — Regular session Shares of Joby Aviation, Inc. (JOBY) dropped 6.7% to $14.37 by 10:49 a.m. EST, wiping out an initial gain as the stock swung sharply lower. So far, the price has moved between $15.93 and $14.16, with roughly 11.6 million shares traded. The decline followed new U.S. inflation figures that failed to boost bets on near-term rate cuts. December saw consumer prices climb 0.3%, while core inflation, excluding food and energy, edged up 0.2%. That left annual rates steady at 2.7% for overall and 2.6% for core. (Reuters) This is crucial
13 January 2026
·······
MARA stock steadies as Bitdeer closes in on mining lead; Washington crypto bill in focus

MARA stock steadies as Bitdeer closes in on mining lead; Washington crypto bill in focus

NEW YORK, Jan 13, 2026, 10:43 EST — Regular session MARA Holdings, Inc. shares edged up 0.1% to $10.66 on Tuesday, mirroring a bitcoin increase during the U.S. morning session. The stock stands at a crossroads between two rapid developments: which players can continue ramping up computing power in a fiercely competitive mining space, and whether Washington will roll out regulations that either simplify crypto ownership or tighten the screws on operations. The mix can shift fast. When bitcoin holds steady, miners usually see a boost. But when profits tighten, it’s leadership on output and uptime that takes center stage—more
13 January 2026
·····
Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets

Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets

NEW YORK, Jan 13, 2026, 10:45 EST — Regular session Netflix shares inched up 4 cents on Tuesday after Paramount Skydance filed suit against Warner Bros Discovery to force more disclosure around Warner’s agreement with Netflix, keeping the takeover fight in play. The stock was up 0.05% at $89.45, after trading between $88.90 and $90.97. (The Verge) The courtroom push matters because it drags the dispute out of press releases and into Delaware, where timeline and detail can shift fast. For Netflix, the noise lands at an awkward moment: investors are trying to decide whether the Warner deal is a
13 January 2026
·······
Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

New York, Jan 13, 2026, 10:50 (EST) — Regular session Pfizer Inc (PFE) shares slipped about 0.7% to $25.10 Tuesday morning as investors digested the company’s latest obesity drug strategy unveiled at the J.P. Morgan Healthcare Conference in San Francisco. CEO Albert Bourla described the booming out-of-pocket weight-loss market as “almost like Viagra” now. Pfizer aims to launch 10 phase 3 trials for its Metsera obesity drugs by the end of 2026. The company has indicated it doesn’t expect revenue growth to resume until 2029. (Reuters) The obesity market has turned into a fierce arena for deals and capital spending
13 January 2026
·····
ImmunityBio stock pops on ANKTIVA lung cancer data; what IBRX investors watch next

ImmunityBio stock pops on ANKTIVA lung cancer data; what IBRX investors watch next

New York, Jan 13, 2026, 10:45 (EST) — Regular session ImmunityBio, Inc. shares rose about 6% on Tuesday after the company released new lung cancer trial results tied to its immune-boosting drug ANKTIVA. The stock was up 6.4% at $2.76, after touching $2.85 earlier in the session. The move matters because ImmunityBio is trying to widen the case for ANKTIVA beyond its current franchise, and lung cancer is where drug makers chase scale. Traders have been quick to react to any read-through on whether the company can turn trial data into a clearer path for new use cases. In a
13 January 2026
·····
Navitas Semiconductor stock slides 7% as NVTS swings ahead of CEO’s Needham conference slot

Navitas Semiconductor stock slides 7% as NVTS swings ahead of CEO’s Needham conference slot

NEW YORK, Jan 13, 2026, 10:30 EST — Regular session Navitas Semiconductor Corp shares were down 7.1% at $9.69 in late-morning trading on Tuesday, after swinging from an intraday high of $10.96 to a low of $9.69. The move stood out against a steadier semiconductor tape, with traders focused on near-term catalysts rather than a fresh headline from the company. Navitas, a small-cap power chipmaker, sells devices based on gallium nitride and silicon carbide — “wide-bandgap” materials that can switch power faster and waste less energy than traditional silicon, making them attractive for high-density power systems. The stock had closed
13 January 2026
····
1 … 306 307 308 309 310 … 880

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop